Global Aortic Repair Devices Market Size Anticipated to Exceeds USD 11.1 Billion by 2035 with a CAGR of 9.14%.

The Global Aortic Repair Devices Market Size is foreseen to grow from USD 4.63 Billion in 2025 and is govern to reach around USD 11.1 Billion by 2035. According to Spherical Insights, a detailed research report on the Global Aortic Repair Devices Market is boosted by Rapid shift toward minimally invasive endovascular procedures, accounting for nearly up to the 10- 0 share of the total share worldwide. Medtronic plc is the prime player in the market with approximately USD 1.5 Billion in annual turnover and a 20 25  market share, positioning it as the primary driver of the global aortic repair devices market.

 

Market Snapshot

• Global Aortic Repair Devices Market Size (2025): USD 4.63 Billion
• Projected Global Aortic Repair Devices Market Size (2035): USD 11.1 Billion
• Global Aortic Repair Devices Market Compound Annual Growth Rate (CAGR): 9.14%
• Largest Regional Market: North America
• Fastest Growing Region: Asia Pacific
• 2^nd Largest Region: Europe
• Base Year: 2025
• Historical Period: 2021–2024
• Forecast Period: 2026–2035

Market Overview/ Introduction

The Global Aortic Repair Devices Market as the high-tech industry propelled to fixing the body’s main pipeline, the aorta. When this huge artery weakens or bulges (an aneurysm), it becomes a ticking time bomb, so doctors use specialised tools like stent grafts to reinforce it from the inside. This growth isn't just about numbers, it's being driven by the fact that we’re living longer, and as we age, our arteries need more maintenance. The real game-changer lately has been the shift away from scary, open-chest surgeries toward minimally invasive SOPs (EVAR). Instead of a large operation, surgeons can now thread repairs through a minute incision, meaning patients get back on their feet much faster. While North America currently leads the charge because of its advanced hospitals, regions like the Asia-Pacific are fitching up quickly as they modernise their healthcare. Top companies like Medtronic and Gore are even using AI and 3D imaging to make these repairs more precise than ever, essentially turning life-saving surgery into a high-precision tech feat.

 

Notable Insights: -

1. North America is anticipated to hold the largest share, approximately 42% of the global aortic repair devices market over the predicted timeframe.
2. Asia Pacific is expected to grow at the fastest CAGR in the global aortic repair devices market during the forecast period, with growth rates estimated at around 8.5% CAGR.
3. By product type, the abdominal aortic stent graft segment dominated the market in 2025 with approximately 45% share, and is projected to grow at a substantial CAGR during the forecast period.
4. By end user, the hospitals segment dominated the market in 2025 with approximately 70% share, and is projected to grow at a substantial CAGR during the forecast period
5. The compound annual growth rate of the global aortic repair devices market is 9.14%.
6. The market is likely to achieve a valuation of USD 11.1 Billion by 2035.

 

What is the role of technology in grooming the market?

Technology plays a crucial role in improving procedural outcomes in aortic repair. Innovations such as next-generation stent grafts with enhanced flexibility, branched and fenestrated grafts, and AI-based imaging systems enable precise placement and better patient-specific treatment. Additionally, 3D printing and patient-specific device customization are improving surgical planning, while robot-assisted endovascular procedures are enhancing precision and reducing complications.

 

Market Drivers

The growth in this market is a mix of better detection and easier fixes. The biggest driver is simply that we’re living longer; as the global population ages, our internal plumbing naturally needs more upkeep, leading to a higher demand for aortic repairs. At the same time, technology has made these procedures far less intimidating. We’ve moved away from the era of massive, high-risk surgeries toward minimally invasive keyhole procedures. Because these new methods use tiny incisions and smart, flexible materials like nitinol, patients aren't stuck in a hospital bed for weeks they’re often heading home in just a few days. On top of that, doctors are getting better at spotting trouble before it starts, thanks to AI-enhanced imaging and routine screening programs. We’re catching these ticking time bombs early and fixing them safely. In short, the market is booming because we’ve finally reached a point where life-saving heart surgery feels less like a major ordeal and more like a high-tech tune-up.

 

Restrain

Despite strong growth, the market faces several challenges. The high cost of aortic repair procedures and devices limits adoption in cost-sensitive regions. Additionally, complications such as endoleaks, device migration, and long-term durability concerns may impact clinical outcomes. Strict regulatory approvals and the need for specialized surgical expertise also act as barriers to market expansion.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global aortic repair devices market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Companies in the Global Aortic Repair Devices Market

1. Medtronic plc
2. W. L. Gore & Associates, Inc.
3. Cook Medical Inc.
4. Terumo Corporation (Terumo Aortic)
5. Endologix LLC
6. MicroPort Scientific Corporation
7. Cardinal Health, Inc.
8. Artivion, Inc. (formerly CryoLife Inc.)
9. Lombard Medical Technologies
10. JOTEC GmbH

 

Government Initiatives

Country	Key Government Initiatives
India	National Medical Devices Policy (2023): Targets industry growth from USD 11B to USD 50B by 2030. PLI Scheme: 3,420 crore approved to incentivise domestic cardiovascular and surgical device production. SMDI Scheme 2024–27: 500 crore for MedTech clusters, testing facilities, and clinical validation.
China	Made in China 2025 Policy: Prioritises cardiovascular device manufacturing, with CNY 1.3 trillion industry revenue support. Government-backed R&D Grants: Focus on endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR)
Europe	EU Medical Device Regulation (MDR 2021): Stricter compliance for stent graft safety. Horizon Europe Program: €95B R&D funding, including biomaterials and vascular graft technologies. National Healthcare Investments: UK & Germany upgrading surgical infrastructure for aneurysm repair.

 

Study on the Supply, Demand, Distribution, and Market Environment of the Global Aortic Repair Devices Market

The global aortic repair devices market demonstrates a strong and steadily growing supply–demand dynamic, primarily driven by the increasing prevalence of aortic aneurysms and rising adoption of endovascular procedures. Hospitals account for nearly 70% of total demand, with cardiovascular interventions contributing to over 60% of overall device usage. On the supply side, approximately 65% of production is concentrated among leading manufacturers such as Medtronic, Gore, and Cook Medical, ensuring consistent global availability. Distribution is largely hospital-centric, supported by specialised cardiac centres, while emerging markets are witnessing expanding distribution networks. Overall, the market environment remains favourable, supported by a 6.6% CAGR, increasing healthcare investments, and growing preference for minimally invasive treatments.

 

Price Analysis and Consumer Behaviour Analysis

The global aortic repair devices market is characterised by high-cost, high-value products, with aortic stent graft systems typically priced between USD 8,000 and USD 20,000 per procedure, depending on complexity and device type. Despite the premium pricing, nearly 70% of purchasing decisions are driven by hospitals, where clinicians prioritise clinical outcomes, durability, and reduced complication rates over cost. Additionally, the ability of endovascular repair procedures to reduce hospital stay by 35% and lower post-operative complications by nearly 25% significantly influences consumer behaviour, making these devices a cost-effective choice in the long term. Emerging markets, however, remain price-sensitive, where affordability and reimbursement policies play a crucial role in adoption.

 

Market Segmentation

The Global Aortic Repair Devices Market share is classified into product type, application, and end user.

• The abdominal aortic stent graft segment dominated the market in 2025 with approximately 45% share, and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the global aortic repair devices market is divided into abdominal aortic stent grafts, thoracic aortic stent grafts, and fenestrated & branched stent grafts. Among these, the abdominal aortic stent graft segment dominated the market in 2025 with approximately 45% share, owing to the high prevalence of abdominal aortic aneurysms (AAA) and the widespread adoption of endovascular aneurysm repair (EVAR) procedures. For instance, these devices are extensively used due to their minimally invasive nature and high procedural success rates. Additionally, advancements in device design, flexibility, and delivery systems have improved clinical outcomes and safety, boosting adoption. Fenestrated and branched stent grafts are expected to witness the fastest growth due to their effectiveness in treating complex aortic anatomies.

 

• The abdominal aortic aneurysm (AAA) segment accounted for the largest share in 2025 with approximately 55% share, and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the global aortic repair devices market is divided into abdominal aortic aneurysm, thoracic aortic aneurysm, and aortic dissection. Among these, the abdominal aortic aneurysm segment accounted for the largest share in 2025 with approximately 55%, driven by its higher global incidence and increasing screening programs for early detection. For example, aortic repair devices are widely used in AAA procedures to prevent rupture and improve survival rates. Moreover, the growing adoption of minimally invasive endovascular techniques is enhancing treatment outcomes and driving demand. The aortic dissection segment is also gaining traction due to rising emergency cases and improved diagnostic capabilities.

 

• The hospitals segment dominated the market in 2025 with approximately 70% share, and is projected to grow at a substantial CAGR during the forecast period.

Based on the end user, the global aortic repair devices market is divided into hospitals, ambulatory surgical centers, and specialty clinics. Among these, the hospitals segment dominated the market in 2025 with approximately 70% share, due to high surgical volumes, availability of advanced imaging systems, and presence of skilled vascular surgeons. For instance, hospitals handle complex aortic repair procedures, including EVAR and TEVAR, requiring specialised infrastructure and post-operative care. Furthermore, increasing healthcare investments and the adoption of advanced endovascular technologies are supporting segment growth. Ambulatory surgical centres are expected to grow rapidly due to the rising preference for minimally invasive and outpatient procedures.

 

 

Strategies to Implement for Growth of the Market in Non-Leading Regions

To drive growth in non-leading regions, companies in the aortic repair devices market should focus on cost optimisation, local manufacturing, and strategic partnerships with hospitals and cardiac centres to improve accessibility. Introducing affordable stent graft systems and expanding distribution networks can significantly enhance adoption in price-sensitive markets, where approximately 63% of healthcare facilities face budget constraints. Additionally, investing in surgeon training programs and clinical awareness initiatives can increase procedural adoption rates by up to 27%. Government support, improving healthcare infrastructure, and rising cardiovascular disease burden in emerging economies are expected to further accelerate market penetration, with these regions projected to grow at over 8% CAGR during the forecast period.

 

Regional Segment Analysis of the Global Aortic Repair Devices Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share, approximately 42% of the Global Aortic Repair Devices Market over the predicted timeframe.

North America is anticipated to hold the largest share, approximately 42% of the Global Aortic Repair Devices Market over the predicted timeframe. The region dominates due to its advanced healthcare infrastructure and high volume of cardiovascular procedures, particularly in the United States and Canada. Additionally, the U.S. performs a significant number of aortic aneurysm repair procedures annually, creating strong and consistent demand for aortic stent graft systems. A key recent development includes the launch of next-generation endovascular stent grafts and branched devices improving procedural outcomes and patient safety. Strict regulatory standards and a strong focus on minimally invasive treatments are further driving adoption, strengthening market dominance.

 

Asia Pacific is expected to grow at the fastest CAGR in the global aortic repair devices market during the forecast period, with growth rates estimated at around 8.5% CAGR.

Asia Pacific is expected to grow at the fastest CAGR in the global aortic repair devices market during the forecast period, with growth rates estimated at around 8.5% CAGR. The region has a rapidly expanding patient population and an increasing burden of cardiovascular diseases, particularly in China and India. Growth is driven by rising healthcare investments, increasing surgical volumes, and improving access to advanced endovascular repair technologies. For instance, countries like India and China are significantly expanding hospital infrastructure and cardiac care facilities, boosting demand for aortic repair devices. Additionally, growing medical tourism and rising awareness about early diagnosis and treatment are accelerating market growth.

 

Europe is the second largest region in the global aortic repair devices market during the forecast period, holding approximately 30% share.

Europe is the second largest region in the global aortic repair devices market during the forecast period, holding approximately 30% share, supported by well-established healthcare systems and strong adoption of advanced vascular technologies. The region benefits from stringent medical device regulations and high standards of patient care, ensuring the use of safe and effective aortic repair devices. Countries such as Germany, France, and the UK lead the market due to high procedural volumes and advanced hospital infrastructure. A recent development includes increased funding for cardiovascular innovation and the adoption of advanced fenestrated and branched stent grafts between 2023–2025, promoting market growth. Additionally, the growing elderly population and rising prevalence of aortic aneurysms are further strengthening demand across the region.

 

Future Market Trends in the Global Aortic Repair Devices Market: -

1.  Rising dominance of minimally invasive endovascular procedures (EVAR & TEVAR)

The market is witnessing a strong shift from open surgical repair to endovascular techniques such as EVAR and TEVAR due to lower mortality, faster recovery, and reduced hospital stays. EVAR alone accounted for over 54% of treatment share in 2025, and continues to expand as the standard of care globally.

 

2. Growth of customised and complex stent-graft technologies (fenestrated & branched devices)

Future innovation is centred around patient-specific and anatomically tailored devices, especially fenestrated and branched EVAR systems. These advanced grafts are enabling treatment of complex aortic anatomies that were previously unsuitable for minimally invasive repair, driving higher-value procedures and expanding the addressable patient pool.

 

3. Integration of advanced imaging, navigation, and hybrid operating environments

Technological advancements such as 3D imaging, fusion-guided navigation, and hybrid operating rooms are significantly improving procedural accuracy and outcomes. These innovations are reducing complication rates and enabling physicians to perform highly precise interventions, accelerating adoption across both developed and emerging healthcare systems.

 

Recent Development

• In January 2025, Medtronic plc launched its next-generation Endurant™ II stent graft system with enhanced delivery precision and improved durability, strengthening its position in endovascular aortic repair (EVAR) procedures globally.

 

• In March 2025, Cook Medical expanded its Zenith Alpha™ Thoracic Endovascular Graft portfolio with advanced low-profile delivery systems, improving access in patients with complex thoracic aortic anatomies.

 

• In June 2024, Terumo Aortic introduced an upgraded RelayPro® Thoracic Stent-Graft System, designed to enhance conformability and deployment accuracy in thoracic endovascular aortic repair (TEVAR) procedures.

 

• In September 2024, W. L. Gore & Associates, Inc. received regulatory approval for its GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System, enabling physicians to achieve more precise placement and better procedural outcomes.

 

• In February 2025, Edwards Lifesciences Corporation advanced its transcatheter aortic valve replacement (TAVR) portfolio by introducing improved valve platforms aimed at treating patients with aortic stenosis and expanding into broader risk categories.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decision Advisors has segmented the global aortic repair devices market based on the below-mentioned segments: 

 

Global Aortic Repair Devices Market, By Product Type

• Endovascular Stent Grafts (EVAR Devices)
• Thoracic Endovascular Aortic Repair (TEVAR Devices)
• Surgical Grafts (Open Repair Devices)
• Hybrid Aortic Repair Devices

 

Global Aortic Repair Devices Market, By Application

• Abdominal Aortic Aneurysm (AAA) Repair
• Thoracic Aortic Aneurysm (TAA) Repair
• Aortic Dissection
• Others

 

Global Aortic Repair Devices Market, By End User

• Hospitals
• Ambulatory Surgical Centres
• Specialty Clinics

 

Global Aortic Repair Devices Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

1. How is reimbursement policy impacting the adoption of aortic repair devices globally?

Reimbursement frameworks vary significantly across countries, and favorable policies in developed markets are accelerating adoption, while limited or inconsistent reimbursement in emerging economies can restrict patient access to advanced aortic repair procedures.

 

2. What role do clinical trials play in shaping the aortic repair devices market?

Ongoing clinical trials are critical for validating the safety and long-term efficacy of next-generation stent grafts and transcatheter devices, influencing regulatory approvals and physician adoption rates.

 

3. How are supply chain disruptions affecting the availability of aortic repair devices?

Global supply chain challenges, including raw material shortages and logistics constraints, can impact device manufacturing and timely delivery, particularly affecting emerging markets with limited local production capabilities.

 

4. What is the impact of physician training and expertise on market growth?

The adoption of advanced endovascular procedures depends heavily on skilled vascular surgeons and interventional specialists; regions with limited training infrastructure may experience slower adoption rates.

 

5. How is digital health integration influencing post-operative care in aortic repair?

The use of remote monitoring tools and digital health platforms is improving post-surgical follow-up, enabling early detection of complications and enhancing long-term patient outcomes.